- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.26 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x 1UG: 2-Amino-5-(1-naphthylsulfanyl)-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one(Non-covalent)
1UG.2: 12 residues within 4Å:- Chain A: R.300, E.337, I.358, W.359, N.362, L.442, L.472, F.476, M.564, A.565, V.566
- Ligands: UMP.1
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:I.358, A:W.359, A:L.472
- Hydrogen bonds: A:R.300, A:N.362, A:A.565
- pi-Stacking: A:W.359, A:F.476
1UG.6: 11 residues within 4Å:- Chain B: I.358, W.359, N.362, D.469, L.472, G.473, F.476, Y.509, M.564, A.565
- Ligands: UMP.5
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:I.358, B:L.472, B:F.476, B:M.564
- Hydrogen bonds: B:N.362, B:Y.509, B:A.565, B:A.565
- Salt bridges: B:D.469
- pi-Stacking: B:W.359, B:W.359
- 2 x FOL: FOLIC ACID(Non-covalent)
FOL.3: 15 residues within 4Å:- Chain A: V.8, V.9, A.10, D.31, F.32, K.33, F.35, S.36, M.62, F.66, L.69, R.72, V.126, T.147
- Ligands: NDP.4
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:F.32, A:F.35
- Hydrogen bonds: A:V.8, A:S.36, A:T.147, A:T.147
- Salt bridges: A:D.31, A:R.72
- pi-Stacking: A:F.32
FOL.7: 15 residues within 4Å:- Chain B: V.8, V.9, A.10, W.25, D.31, F.32, F.35, S.36, M.62, F.66, L.69, R.72, V.126, T.147
- Ligands: NDP.8
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:F.35, B:F.66
- Hydrogen bonds: B:V.8, B:F.32, B:T.147, B:T.147
- Salt bridges: B:D.31, B:R.72
- pi-Stacking: B:F.32
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.4: 29 residues within 4Å:- Chain A: V.9, A.10, I.17, G.18, I.19, N.21, G.22, L.23, W.25, G.55, R.56, K.57, T.58, S.61, V.77, S.78, S.79, S.80, A.103, V.126, G.127, G.128, A.129, G.130, L.131, Y.132, A.134, V.157
- Ligands: FOL.3
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:T.58
- Hydrogen bonds: A:A.10, A:I.17, A:I.19, A:N.21, A:G.55, A:R.56, A:R.56, A:K.57, A:T.58, A:S.61, A:S.79, A:S.79, A:S.80, A:G.127, A:G.128, A:A.129, A:G.130, A:G.130
- Salt bridges: A:R.56
NDP.8: 25 residues within 4Å:- Chain B: V.9, A.10, I.17, G.18, I.19, N.21, G.22, W.25, G.55, R.56, K.57, T.58, S.61, V.77, S.78, S.79, V.126, G.128, A.129, G.130, L.131, Y.132, A.134, V.157
- Ligands: FOL.7
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:T.58
- Hydrogen bonds: B:A.10, B:I.17, B:I.19, B:G.22, B:R.56, B:K.57, B:T.58, B:T.58, B:T.58, B:S.61, B:S.61, B:S.78, B:S.79, B:G.128, B:A.129, B:G.130
- Salt bridges: B:R.56, B:K.57, B:K.57
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zaware, N. et al., Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections. ACS Med Chem Lett (2013)
- Release Date
- 2014-08-06
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.26 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x 1UG: 2-Amino-5-(1-naphthylsulfanyl)-3,9-dihydro-4H-pyrimido[4,5-b]indol-4-one(Non-covalent)
- 2 x FOL: FOLIC ACID(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zaware, N. et al., Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections. ACS Med Chem Lett (2013)
- Release Date
- 2014-08-06
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D